In MNA-NB, YKL-5-124 induces cell cycle abnormalities and significantly inhibits tumor cell growth and the development of patient-derived xenografts when combined with the BRD4 inhibitor JQ1 (Gao et al., 2021). This evidence concerns the gene BRD4 and neuroblastoma.